Literature DB >> 11112286

Use of sulfobutyl ether beta-cyclodextrin as a vehicle for D-threo-1-phenyl-2-decanoylamino-3-morpholinopropanol-relat ed glucosylceramide synthase inhibitors.

A Abe1, S Gregory, L Lee, J A Shayman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112286     DOI: 10.1006/abio.2000.4874

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


× No keyword cloud information.
  1 in total

1.  Decreased nitric oxide bioavailability in a mouse model of Fabry disease.

Authors:  Liming Shu; James L Park; Jaeman Byun; Subramaniam Pennathur; Jessica Kollmeyer; James A Shayman
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.